Related Experiment Videos
[Acute lung failure following thoracic trauma].
C Putensen1, U Waibel, W Koller
1Universitätsklinik für Anaesthesie und Allgemeine Intensivmedizin, Innsbruck.
Der Anaesthesist
|October 1, 1990
Summary
Direct thoracic trauma causes early acute lung failure (ALF) by increasing pulmonary microvascular permeability (PMVP). Later increases in PMVP in healthy lung areas suggest a broader inflammatory response in trauma patients.
Area of Science:
- Trauma and Critical Care Medicine
- Pulmonary Medicine
- Pathophysiology
Background:
- Acute lung failure (ALF) is a common complication in multiple organ failure (MOF).
- Increased pulmonary microvascular permeability (PMVP) is a key factor in ALF development.
- Understanding the sequence of PMVP and ALF after direct lung insults is crucial.
Purpose of the Study:
- To investigate the sequence of PMVP and ALF development following direct lung insults in trauma patients.
- To differentiate between early and late ALF manifestations and their underlying mechanisms.
- To assess the role of thoracic injury in posttraumatic ALF.
Main Methods:
- Prospective study of 255 trauma patients in an ICU.
- Defined ALF, sepsis syndrome, and MOF using established scoring systems.
- Measured PMVP using gamma camera scintigraphy with specific radiotracers (113mIn-transferrin and 99mTc-erythrocytes).
- Quantified PMVP using the pulmonary microvascular permeability index (PMVPI).
Main Results:
- 21% of trauma patients developed ALF, with 96% also developing MOF.
- Direct lung injury, particularly thoracic trauma, was the primary cause of early ALF (within 72 hours).
- Direct thoracic injury initially increased PMVP in the injured lung, followed by a significant increase in the contralateral lung within 4 days.
Conclusions:
- Direct lung injury, especially thoracic trauma, is the dominant mechanism for early posttraumatic ALF.
- Increased PMVP in injured lung areas is an early indicator of ALF.
- A subsequent inflammatory response may lead to increased PMVP in previously healthy lung regions, contributing to late-phase ALF.